<?xml version="1.0"?>
<rss version="2.0">
   <channel>
      <title>Q&amp;A by Georgouli Loupi, Maria</title>
      <link>https://padlet.com/mgeorgouliloup2/v7d6itara8ov4np9</link>
      <description>For your Corporate Finance Assessment</description>
      <language>en-us</language>
      <pubDate>2022-02-22 10:54:07 UTC</pubDate>
      <lastBuildDate>2025-12-11 18:47:07 UTC</lastBuildDate>
      <webMaster>hello@padlet.com</webMaster>
      <image>
         <url></url>
      </image>
      <item>
         <title>Structure</title>
         <author></author>
         <link>https://padlet.com/mgeorgouliloup2/v7d6itara8ov4np9/wish/2062528851</link>
         <description><![CDATA[<div>What structure do you expect?</div>]]></description>
         <enclosure url="" />
         <pubDate>2022-02-23 13:01:10 UTC</pubDate>
         <guid>https://padlet.com/mgeorgouliloup2/v7d6itara8ov4np9/wish/2062528851</guid>
      </item>
      <item>
         <title>Does the company have the same class of shares?</title>
         <author></author>
         <link>https://padlet.com/mgeorgouliloup2/v7d6itara8ov4np9/wish/2062844920</link>
         <description><![CDATA[]]></description>
         <enclosure url="" />
         <pubDate>2022-02-23 15:43:09 UTC</pubDate>
         <guid>https://padlet.com/mgeorgouliloup2/v7d6itara8ov4np9/wish/2062844920</guid>
      </item>
      <item>
         <title>is intellectual property a form of non-cash consideration?</title>
         <author></author>
         <link>https://padlet.com/mgeorgouliloup2/v7d6itara8ov4np9/wish/2063303818</link>
         <description><![CDATA[]]></description>
         <enclosure url="" />
         <pubDate>2022-02-23 19:55:16 UTC</pubDate>
         <guid>https://padlet.com/mgeorgouliloup2/v7d6itara8ov4np9/wish/2063303818</guid>
      </item>
      <item>
         <title>Does creating new class of shares alter the existing share capital?</title>
         <author></author>
         <link>https://padlet.com/mgeorgouliloup2/v7d6itara8ov4np9/wish/2063305199</link>
         <description><![CDATA[]]></description>
         <enclosure url="" />
         <pubDate>2022-02-23 19:56:12 UTC</pubDate>
         <guid>https://padlet.com/mgeorgouliloup2/v7d6itara8ov4np9/wish/2063305199</guid>
      </item>
      <item>
         <title>can you still offer a floating charge if you have an asset which can be used for a fixed charge? </title>
         <author></author>
         <link>https://padlet.com/mgeorgouliloup2/v7d6itara8ov4np9/wish/2064385103</link>
         <description><![CDATA[]]></description>
         <enclosure url="" />
         <pubDate>2022-02-24 11:21:23 UTC</pubDate>
         <guid>https://padlet.com/mgeorgouliloup2/v7d6itara8ov4np9/wish/2064385103</guid>
      </item>
      <item>
         <title>Do you expect us to discuss both of fixed charge and floating charge? Or focus only one of the charges?</title>
         <author></author>
         <link>https://padlet.com/mgeorgouliloup2/v7d6itara8ov4np9/wish/2064765964</link>
         <description><![CDATA[]]></description>
         <enclosure url="" />
         <pubDate>2022-02-24 15:24:46 UTC</pubDate>
         <guid>https://padlet.com/mgeorgouliloup2/v7d6itara8ov4np9/wish/2064765964</guid>
      </item>
      <item>
         <title>Level of detail part (a)</title>
         <author></author>
         <link>https://padlet.com/mgeorgouliloup2/v7d6itara8ov4np9/wish/2065060314</link>
         <description><![CDATA[<div>What level of detail are we expected to go into for part (a)? Due to the word limit is it simply just making the client aware of the types of charges, what they mean then advantages and disadvantages. Or is more detailed required in terms of explaining how legal/equitable interest operate etc?</div>]]></description>
         <enclosure url="" />
         <pubDate>2022-02-24 18:03:38 UTC</pubDate>
         <guid>https://padlet.com/mgeorgouliloup2/v7d6itara8ov4np9/wish/2065060314</guid>
      </item>
      <item>
         <title>Can we offer both fixed charge and floating charge to the creditors?</title>
         <author></author>
         <link>https://padlet.com/mgeorgouliloup2/v7d6itara8ov4np9/wish/2067723423</link>
         <description><![CDATA[]]></description>
         <enclosure url="" />
         <pubDate>2022-02-26 20:02:11 UTC</pubDate>
         <guid>https://padlet.com/mgeorgouliloup2/v7d6itara8ov4np9/wish/2067723423</guid>
      </item>
      <item>
         <title>Reading list </title>
         <author></author>
         <link>https://padlet.com/mgeorgouliloup2/v7d6itara8ov4np9/wish/2070231971</link>
         <description><![CDATA[<div>Can you suggest us any text book about Guarantees?? cause I have a struggle to find it </div>]]></description>
         <enclosure url="" />
         <pubDate>2022-02-28 20:05:24 UTC</pubDate>
         <guid>https://padlet.com/mgeorgouliloup2/v7d6itara8ov4np9/wish/2070231971</guid>
      </item>
      <item>
         <title>Structure</title>
         <author></author>
         <link>https://padlet.com/mgeorgouliloup2/v7d6itara8ov4np9/wish/2070268048</link>
         <description><![CDATA[<div>Would it be acceptable to use bullet points within the advise (with the use of full sentences) or would you prefer the advise to be presented entirely in paragraph form? </div>]]></description>
         <enclosure url="" />
         <pubDate>2022-02-28 20:31:22 UTC</pubDate>
         <guid>https://padlet.com/mgeorgouliloup2/v7d6itara8ov4np9/wish/2070268048</guid>
      </item>
      <item>
         <title></title>
         <author></author>
         <link>https://padlet.com/mgeorgouliloup2/v7d6itara8ov4np9/wish/2070335073</link>
         <description><![CDATA[<div>for section a, are the advantages and disadvantages supposed to be for the charges themselves or for the bank or the company? </div>]]></description>
         <enclosure url="" />
         <pubDate>2022-02-28 21:27:36 UTC</pubDate>
         <guid>https://padlet.com/mgeorgouliloup2/v7d6itara8ov4np9/wish/2070335073</guid>
      </item>
      <item>
         <title>Citing cases</title>
         <author></author>
         <link>https://padlet.com/mgeorgouliloup2/v7d6itara8ov4np9/wish/2071256944</link>
         <description><![CDATA[<div>Is it acceptable to simply footnote all of the cases used instead of citing the case names directly within the work itself?</div>]]></description>
         <enclosure url="" />
         <pubDate>2022-03-01 11:13:41 UTC</pubDate>
         <guid>https://padlet.com/mgeorgouliloup2/v7d6itara8ov4np9/wish/2071256944</guid>
      </item>
      <item>
         <title></title>
         <author></author>
         <link>https://padlet.com/mgeorgouliloup2/v7d6itara8ov4np9/wish/2072327070</link>
         <description><![CDATA[<div>is S171 CA 2006 relevant to private companies?</div>]]></description>
         <enclosure url="" />
         <pubDate>2022-03-01 21:12:50 UTC</pubDate>
         <guid>https://padlet.com/mgeorgouliloup2/v7d6itara8ov4np9/wish/2072327070</guid>
      </item>
      <item>
         <title>Prescribed part</title>
         <author></author>
         <link>https://padlet.com/mgeorgouliloup2/v7d6itara8ov4np9/wish/2073911830</link>
         <description><![CDATA[<div>Is the maximum of the prescribed part £800,000 or £600,000?&nbsp;<br><br>(s3, The Insolvency Act 1986 (Prescribed Part) Order 2003 says £600,000 but the powerpoint says £800,000.</div>]]></description>
         <enclosure url="" />
         <pubDate>2022-03-02 16:21:01 UTC</pubDate>
         <guid>https://padlet.com/mgeorgouliloup2/v7d6itara8ov4np9/wish/2073911830</guid>
      </item>
      <item>
         <title>Sources</title>
         <author></author>
         <link>https://padlet.com/mgeorgouliloup2/v7d6itara8ov4np9/wish/2076416931</link>
         <description><![CDATA[<div>Are we expected to only use case law in addressing this question (as this is legal advice)?&nbsp;<br><br>Or is it completely fine to cite secondary sources (e.g. the textbook) which contain good explanations for certain issues?</div>]]></description>
         <enclosure url="" />
         <pubDate>2022-03-03 18:24:32 UTC</pubDate>
         <guid>https://padlet.com/mgeorgouliloup2/v7d6itara8ov4np9/wish/2076416931</guid>
      </item>
      <item>
         <title></title>
         <author></author>
         <link>https://padlet.com/mgeorgouliloup2/v7d6itara8ov4np9/wish/2077604213</link>
         <description><![CDATA[<div>Do you need to explain what I charge is before you discuss the possible charges the company could offer or just go straight into identifying them?</div>]]></description>
         <enclosure url="" />
         <pubDate>2022-03-04 09:15:56 UTC</pubDate>
         <guid>https://padlet.com/mgeorgouliloup2/v7d6itara8ov4np9/wish/2077604213</guid>
      </item>
      <item>
         <title></title>
         <author></author>
         <link>https://padlet.com/mgeorgouliloup2/v7d6itara8ov4np9/wish/2078747876</link>
         <description><![CDATA[<div>Do we have to use the title on each answer or straight to the answer? For example, 1. The potential charge (then answer) or 1. Answer. </div>]]></description>
         <enclosure url="" />
         <pubDate>2022-03-05 00:03:41 UTC</pubDate>
         <guid>https://padlet.com/mgeorgouliloup2/v7d6itara8ov4np9/wish/2078747876</guid>
      </item>
      <item>
         <title>Reading list</title>
         <author></author>
         <link>https://padlet.com/mgeorgouliloup2/v7d6itara8ov4np9/wish/2080233781</link>
         <description><![CDATA[<div>can you suggest us the reading list that related to issue non-cash consideration? thank you<br><br></div>]]></description>
         <enclosure url="" />
         <pubDate>2022-03-06 20:20:59 UTC</pubDate>
         <guid>https://padlet.com/mgeorgouliloup2/v7d6itara8ov4np9/wish/2080233781</guid>
      </item>
      <item>
         <title>Question c.</title>
         <author></author>
         <link>https://padlet.com/mgeorgouliloup2/v7d6itara8ov4np9/wish/2081446548</link>
         <description><![CDATA[<div>Do we need to explain the formalities of issuing and allotting new shares?</div>]]></description>
         <enclosure url="" />
         <pubDate>2022-03-07 11:29:45 UTC</pubDate>
         <guid>https://padlet.com/mgeorgouliloup2/v7d6itara8ov4np9/wish/2081446548</guid>
      </item>
      <item>
         <title>Names</title>
         <author></author>
         <link>https://padlet.com/mgeorgouliloup2/v7d6itara8ov4np9/wish/2083906852</link>
         <description><![CDATA[<div>Are we expected to include the full name of the company at the start e.g. Cornwall Lithium Exploration Co Ltd (“the Company”) and thereafter refer to it as "the Company"?<br><br>Or can we just refer to it as "the Company" throughout the work without mentioning "Cornwall Lithium Exploration Co Ltd"?&nbsp;</div>]]></description>
         <enclosure url="" />
         <pubDate>2022-03-08 12:51:32 UTC</pubDate>
         <guid>https://padlet.com/mgeorgouliloup2/v7d6itara8ov4np9/wish/2083906852</guid>
      </item>
      <item>
         <title>Padlet now closed</title>
         <author>npointon3</author>
         <link>https://padlet.com/mgeorgouliloup2/v7d6itara8ov4np9/wish/2086333459</link>
         <description><![CDATA[<div>Since the deadline for submission of the First Summative Assessment has now passed, this Padlet is now closed. The questions asked and answers given will remain visible for those who have opted to take extensions, but in fairness to those who have now submitted no further questions will be answered. </div>]]></description>
         <enclosure url="" />
         <pubDate>2022-03-09 15:36:05 UTC</pubDate>
         <guid>https://padlet.com/mgeorgouliloup2/v7d6itara8ov4np9/wish/2086333459</guid>
      </item>
   </channel>
</rss>
